TNON
Tenon Medical, Inc.1.1000
+0.0200+1.85%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
FY Q3 '25
Key Stats
Market Cap
12.22MP/E (TTM)
0.19Basic EPS (TTM)
5.86Dividend Yield
0%Recent Filings
8-K
10-Q
Q3 FY2025 results
Tenon Medical posted Q3 revenue of $1.2M, up 32% y/y from $887K yet down q/q (derived), with gross margin leaping to 66% from 47% on lower costs and volume leverage. Operating loss narrowed to $3.4M from $3.2M y/y as R&D dropped 35%, though G&A spiked on $779K acquisition costs; net loss tracked closely at $3.3M. Closed SI Acquisition in August 2025 for $3.1M (cash/stock/contingent), recognizing $2.4M goodwill and $509K intangibles (7-10 years). Cash fell to $3.4M after $8.5M operating burn, no debt. Shares exploded to 8.6M from 877K, slashing diluted EPS to -$0.40 from -$3.63. Acquisitions expand the arsenal. Competition bites hard.
8-K
8-K
10-Q
Q2 FY2025 results
Tenon Medical's Q2 revenue fell 37% y/y to $564K yet narrowed operating loss to $2.9M from $3.9M, trimming op ex 29% via lower stock-based comp and insurance. Gross margin slipped to 43% from 52% on higher relative fixed costs, while YTD revenue dropped 20% to $1.3M with $6.4M net loss versus $7.4M prior (anti-dilutive shares steady at 5.6M). Cash climbed to $7.8M on $6.2M equity raises, funding $4.7M op cash burn; no debt. Cash fuels the runway. Post-quarter, closed SImmetry asset buy for $0.8M cash plus 710K shares and royalties capped at $5M. Competition shadows SI joint sales.
BSX
Boston Scientific Corporation
92.95+0.76
EW
Edwards Lifesciences Corporatio
85.32+1.94
FZMD
Fuse Medical, Inc.
0.07+0.00
LNSR
LENSAR, Inc.
12.06+0.54
NVNO
enVVeno Medical Corporation
0.32+0.01
SENS
Senseonics Holdings, Inc.
6.62-0.17
SIBN
SI-BONE, Inc.
19.42+1.01
STIM
Neuronetics, Inc.
1.65-0.11
TMCI
Treace Medical Concepts, Inc.
2.70-0.07
XTNT
Xtant Medical Holdings, Inc.
0.73+0.04